Summary of the National Advisory Committee on Immunization (NACI) Supplemental Guidance on Influenza Vaccination in Adults 65 Years of Age and Older
Following a thorough review of the complete body of evidence, NACI recommends that IIV-HD, IIV-Adj or RIV should be offered over other influenza vaccines for adults 65 years of age and older. NACI also continues to strongly recommend the inclusion of adults 65 years of age and older among those for whom it is particularly important to receive influenza vaccination.
Authors
- Paméla Doyon-Plourde (ORCID: https://orcid.org/0000-0002-8738-0055)
- Angela Sinilaité
- Jesse Papenburg (ORCID: https://orcid.org/0000-0003-4232-871X)
Institutions
- Public Health Agency of Canada (CA)
- Montreal Children's Hospital (CA)
- McGill University Health Centre (CA)
- National Influenza Center (MN)
- McGill University (CA)
Publication Details
- Journal
- Canada Communicable Disease Report
- Published
- 2024-11-07
- DOI
- https://doi.org/10.14745/ccdr.v50i11a02
- Citations
- 2
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Public Health Agency of Canada
- Association of Medical Microbiology and Infectious Disease Canada
- Public Health Agency
- Canadian Armed Forces
- Indigenous Services Canada
- Association des pharmaciens du Canada
- Health Canada